Inactivation of soluble guanylate cyclase by stoichiometric S-nitrosation

Molecular Pharmacology

Volumn 75, Issue 4, 2009, Pages 886-891

  Mayer, Bernd ^a   Kleschyov, Andrei L ^b   Stessel, Heike ^a   Russwurm, Michael ^c   Münzel, Thomas ^b   Koesling, Doris ^c   Schmidt, Kurt ^a  

^a UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2,2 DIETHYL 1 NITROSOOXYHYDRAZINE; CYCLIC GMP; GLUTATHIONE; GLYCERYL TRINITRATE; GUANYLATE CYCLASE; HYDRAZINE DERIVATIVE; NITROPRUSSIDE SODIUM; S NITROSOGLUTATHIONE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME INACTIVATION; ENZYME MODIFICATION; NITROSATION; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; STOICHIOMETRY;

ANIMALS; CATTLE; ENZYME INHIBITORS; GUANYLATE CYCLASE; IRON; NITRATES; NITRIC OXIDE; NITROGEN OXIDES; NITROSATION; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SOLUBILITY; STEREOISOMERISM;

EID: 63849335621     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.108.052142     Document Type: Article

References (40)

1. Alencar JL, Chalupsky K, Sarr M, Schini-Kerth V, Vanin AF, Stoclet JC, and Muller B (2003) Inhibition of arterial contraction by dinitrosyl-iron complexes: Critical role of the thiol ligand in determining rate of nitric oxide (NO) release and formation of releasable NO stores by S-nitrosation. Biochem Pharmacol 66:2365-2374.
2. Angelo M, Singel DJ, and Stamler JS (2006) An S-nitrosothiol (SNO) synthase function of hemoglobin that utilizes nitrite as a substrate. Proc Natl Acad Sci USA 103:8366-8371.
3. Bland RD, Ling CY, Albertine KH, Carlton DP, MacRitchie AJ, Day RW, and Dahl MJ (2003) Pulmonary vascular dysfunction in preterm lambs with chronic lung disease. Am J Physiol Lung Cell Mol Physiol 285:L76-L85.
4. Boese M, Mordvintcev PI, Vanin AF, Busse R, and M̈lsch A (1995) S-nitrosation of serum albumin by dinitrosyl-iron complex. J Biol Chem 270:29244-29249.
5. Brault S, Gobeil F Jr, Fortier A, Honoré JC, Joyal JS, Sapieha PS, Kooli A, Martin E, Hardy P, Ribeiro-da-Silva A, et al. (2007) Lysophosphatidic acid induces endothelial cell death by modulating the redox environment. Am J Physiol Regul Integr Comp Physiol 292:R1174-R1183.
6. Chirkov YY and Horowitz JD (2007) Impaired tissue responsiveness to organic nitrates and nitric oxide: A new therapeutic frontier? Pharmacol Ther 116:287-305.
7. Friebe A and Koesling D (2003) Regulation of nitric oxide-sensitive soluble guanylyl cyclase. Circ Res 93:96-105.
8. Friebe A, Schultz G, and Koesling D (1996) Sensitizing soluble guanylyl cyclase to become a highly CO-sensitive enzyme. EMBO J 15:6863-6868.
9. Giannone G, Takeda K, Kleschyov AL, and Kleyschov AL (2000) Novel activation of non-selective cationic channels by dinitrosyl iron-thiosulfate in PC12 cells. J Physiol 529:735-745.
10. Gorren AC, Schrammel Astrid, Schmidt K, and Mayer B (1996) Decomposition of S-nitrosoglutathione in the presence of copper and glutathione. Arch Biochem Biophys 330:219-228.
11. Griffith OW (1999) Biologic and pharmacologic regulation ofmammalian glutathione synthesis. Free Rad Biol Med 27:922-935.
12. Hughes MN (1999) Relationships between nitric oxide, nitroxyl ion, nitrosonium cation and peroxynitrite. Biochim Biophys Acta 1411:263-272.
13. Inoue K, Akaike T, Miyamoto Y, Okamoto T, Sawa T, Otagiri M, Suzuki S, Yo-shimura T, and Maeda H (1999) Nitrosothiol formation catalyzed by ceruloplas-min-implication for cytoprotective mechanism in vivo. J Biol Chem 274:27069-27075.
14. Jacke K, Witte K, and Lemmer B (2001) Mechanisms involved in the blunted nitric oxide-cGMP pathway in hypertensive TGR(MREN2) 27 rats. Eur J Pharmacol 415:27-30.
15. Jaffrey SR, Erdjument-Bromage H, Ferris CD, Tempst P, and Snyder SH (2001) Protein S-nitrosylation: A physiological signal for neuronal nitric oxide. Nat Cell Biol 3:193-197.
16. Kleschyov AL, Strand S, Schmitt S, Gottfried D, Skatchkov M, Sjakste N, Daiber A, Umansky V, and Munzel T (2006) Dinitrosyl-iron triggers apoptosis in Jurkat cells despite overexpression of Bcl-2. Free Rad Biol Med 40:1340 -1348.
17. Laber U, Kober T, Schmitz V, Schrammel A, Meyer W, Mayer B, Weber M, and Kojda G (2002) Effect of hypercholesterolemia on expression and function of vascular soluble guanylyl cyclase. Circulation 105:855-860.
18. Lancaster JR Jr and Hibbs JB Jr (1990) EPR demonstration ofiron-nitrosyl complex formation by cytotoxic activated macrophages. Proc Natl Acad Sci U S A 87:1223-1227.
19. Maragos CM, Morley D, Wink DA, Dunams TM, Saavedra JE, Hoffman A, Bove AA, Isaac L, Hrabie JA, and Keefer LK (1991) Complexes of NO with nucleophiles as agents for the controlled biological release of nitric oxide-vasorelaxant effects. J Med Chem 34:3242-3247.
20. Mayer B and Beretta M (2008) The enigma of nitroglycerin bioactivation and nitrate tolerance: news, views, and troubles. Br J Pharmacol 155:170 -184.
21. Mayer B, Klatt P, Werner ER, and Schmidt K (1995) Kinetics and mechanism of tetrahydrobiopterin-induced oxidation of nitric oxide. J Biol Chem 270:655-659.
22. Moncada S, Palmer RM, and Higgs EA (1991) Nitric oxide-physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109 -142.
23. Monti DM, Montesano Gesualdi N, Matousek J, Esposito F, and D'Alessio G (2007) The cytosolic ribonuclease inhibitor contributes to intracellular redox homeostasis. FEBS Lett 581:930 -934.
24. Muller B, Kleschyov AL, and Stoclet JC (1996) Evidence for N-acetylcysteine- sensitive nitric oxide storage as dinitrosyl-iron complexes in lipopolysaccharide-treated rat aorta. Br J Pharmacol 119:1281-1285.
25. Mülsch A, Mordvintcev P, Vanin AF, and Busse R (1991) The potent vasodilating and guanylyl cyclase activating dinitrosyl-iron(II) complex is stored in a protein-bound form in vascular tissue and is released by thiols. FEBS Lett 294:252-256.
26. Mülsch A, Mordvintcev PI, Vanin AF, and Busse R (1993) Formation and release of dinitrosyl iron complexes by endothelial cells. Biochem Biophys Res Commun 196:1303-1308.
27. Ng ES, Jourd'heuil D, McCord JM, Hernandez D, Yasui M, Knight D, and Kubes P (2004) Enhanced S-nitroso-albumin formation from Inhaled NO during Ischemia/reperfusion. Circ Res 94:559 -565.
28. Ridnour LA, Thomas DD, Mancardi D, Espey MG, Miranda KM, Paolocci N, Feelisch M, Fukuto J, and Wink DA (2004) The chemistry of nitrosative stress induced by nitric oxide and reactive nitrogen oxide species. Putting perspective on stressful biological situations. Biol Chem 385:1-10.
29. Russwurm M and Koesling D (2005) Purification and characterization of NO-sensitive guanylyl cyclase. Methods Enzymol 396:492-501.
30. Saville B (1958) A scheme for the colorimetric determination of microgram amounts of thiols. Analyst 83:670 -672.
31. Sayed N, Baskaran P, Ma X, van den Akker F, and Beuve A (2007) Desensitization of soluble guanylyl cyclase, the NO receptor, by S-nitrosylation. Proc Natl Acad Sci USA104:12312-12317.
32. Sayed N, Kim DD, Fioramonti X, Iwahashi T, Durán WN, and Beuve A (2008) Nitroglycerin-induced S-nitrosylation and desensitization of soluble guanylyl cyclase contribute to nitrate tolerance. Circ Res 103:606-614.
33. Scharfstein JS, Keaney JF Jr, Slivka A, Welch GN, Vita JA, Stamler JS, and Loscalzo J (1994) In vivo transfer of nitric oxide between a plasma protein-bound reservoir and low molecular weight thiols. J Clin Invest 94:1432-1439.
34. Schmidt K, Desch W, Klatt P, Kukovetz WR, and Mayer B (1997) Release of nitric oxide from donors with known half-life: A mathematical model for calculating nitric oxide concentrations in aerobic solutions. Naunyn Schmiedeberg's Arch Pharmacol 355:457-462.
35. Schmidt K, Graier WF, Kostner GM, Mayer B, Böhme E, and Kukovetz WR (1991) Oxidized low-density lipoprotein antagonizes the activation of purified soluble guanylate cyclase by endothelium-derived relaxing factor but does not interfere with its biosynthesis. Cell Signal 3:361-367.
36. Schrammel A, Behrends S, Schmidt K, Koesling D, and Mayer B (1996) Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase. Mol Pharmacol 50:1-5.
37. Schrammel A, Gorren AC, Schmidt K, Pfeiffer S, and Mayer B (2003) S-nitrosation of glutathione by nitric oxide, peroxynitrite, and NO/superoxide. Free Rad Biol Med 34:1078-1088.
38. Schultz G and Bohme E (1984) Guanylate cyclase. GTP pyrophosphate-lyase (cyclizing), E.C. 4.6.1.2, in Methods of Enzymatic Analysis (Bergmeyer HU, Bergmeyer J and Grassl M eds) pp 379 -389, Verlag Chemie, Weinheim, Germany.
39. Severina IS, Bussygina OG, Pyatakova NV, Malenkova IV, and Vanin AF (2003) Activation of soluble guanylate cyclase by NO donors-S-nitrosothiols, and dinitrosyl-iron complexes with thiol-containing ligands. Nitric Oxide 8:155-163.
40. Witte K, Jacke K, Stahrenberg R, Arlt G, Reitenbach I, Schilling L, and Lemmer B (2002) Dysfunction of soluble guanylyl cyclase in aorta and kidney of Goto-Kakizaki rats: influence of age and diabetic state. Nitric Oxide 6:85-95.